Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.
Excellergy develops immunology-based therapies focused on treating allergic diseases through novel biologic drug candidates.
Cypherpunk is a biopharmaceutical company developing antibody therapies for cancer while executing a digital-asset treasury strategy.
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
PepGen is empowering nucleic acid therapeutics to go the distance.
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Enlaza Therapeutics is a biotechnology research company.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Shenandoah Therapeutics is a biotechnology company.
Spyglass Pharma provides medicine for ophthalmic diseases.
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Samsara BioCapital has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Samsara BioCapital's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 16 different industry categories.
Among tracked funding rounds, Janux Therapeutics received $350.0M in a Post-IPO Equity round. Samsara BioCapital's total known invested capital is $14.2B.
Samsara BioCapital's average investment size is $107.7M across its portfolio of 132 companies.
Recent Samsara BioCapital portfolio additions include Psivant Therapeutics, Centessa Pharmaceuticals, Rani Therapeutics, Excellergy, Cypherpunk Technologies (formerly Leap Therapeutics). These companies were founded in 2020 or later.